Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hermatopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 18, Issue 23, 2000, Pages 3918-3924

  Carella, Angelo ^a   Cavaliere, Marina ^a   Lerma, Enrica ^a   Ferrara, Raimondo ^a   Tedeschi, Lucilla ^a   Romanelli, Antonella ^a   Vinci, Maria ^a   Pinotti, Graziella ^a   Lambelet, Paola ^a   Loni, Carlo ^a   Verdiani, Simonetta ^a   De Stefano, Francesco ^a   Valbonesi, Mauro ^a   Corsetti, Maria Teresa ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE;

ADULT; ADVANCED CANCER; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOGRAFT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION;

EID: 0034554782     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.23.3918     Document Type: Article

References (37)

1. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
2. Allogeneic syngeneic and autologous marrow transplantation for Hodgkin's diease: The 21-year Seattle experience
3. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease
4. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
5. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
6. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group registry data
7. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity and survival depend on disease histology
8. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma
9. Treatment of aggressive non-Hodgkin's lymphoma with marrow transplantation
10. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low grade non-Hodgkin's lymphoma
11. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
12. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
13. Transplant-like: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies
14. Mixed lymphohematopoietic chimerism and graft versus lymphoma effect are achievable in adult recipients following non-myeloablative therapy and HLA-mismatched donor bone marrow transplantation
15. Mini-allografting: Ongoing trials in humans
16. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
17. Detection of recipient cells after non T cell depleted marrow transplantation for leukemia by the PCR amplification of minisatellites or a Y chromosome marker has a different prognostic value
18. Myeloid and lymphoid chimerism after T-cell depleted bone marrow transplantation: Evaluation of conditioning regimens using the PCR to amplify human minisatellite regions of genomic DNA
19. A predictive model for aggressive non Hodgkin's lymphoma
20. Role of bone marrow transplantation in Hodgkin's disease
21. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease: A single-center eight-year study of 155 patients
22. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow up in 128 patients
23. High-dose carmustine cyclophosphamide and etoposide with autologous transplantation in Hodgkin's disease: A prognostic model for treatment outcome
24. High dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors
25. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant
26. Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: Factors predictive of prolonged survival
27. Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
28. High dose therapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian Study Group report
29. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
30. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease
31. High-dose therapy and autologous stem cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation
32. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: The case for aggressive management
33. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma
34. Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft versus lymphoma effects
35. Induction of graft versus lymphoma reaction in stage IVB cell non-Hodgkin's lymphoma, after allogeneic peripheral blood stem cell transplant: Comparison of laboratory, radiological and clinical findings
36. Graft vs lymphoma effect of donor leukocyte infusion shown by real-time quantitative PCR analysis of t(14;18)